Obesity - Pipeline Review, H2 2016: Ken Research
The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Obesity and features dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.
The report provides a snapshot of the global therapeutic landscape of Obesity
The report reviews pipeline therapeutics for Obesity by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved Obesity therapeutics and enlists all their major and minor projects
The report assesses Obesity therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news related to pipeline therapeutics for Obesity
Reasons to Buy
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Obesity
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Obesity pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Ankur Gupta, Head Marketing & Communications
Ken Research is a Global aggregator and publisher of Market intelligence research reports, equity reports, data base directories and economy reports. Our market research reports provides market sizing analysis, insights on promising industry segments, competition, future outlook and growth drivers in the space. The company is engaged in data analytics and aids clients in due-diligence, product expansion, plant setup, acquisition intelligence to all the other gamut of objectives through our research focus.
27A, TOWER B-2, SPAZE I TECH BUSINESS PARK, SOHNA ROAD, SECTOR 49
GURGAON, HARYANA - 122001, INDIA
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obesity - Pipeline Review, H2 2016: Ken Research here
News-ID: 510074 • Views: 260
More Releases from Ken Research Pvt Ltd
US Seed Market Outlook to 2023: Ken Research
The report titled “US Seed Market Outlook to 2023 - By Type of Seed (Corn, Soybean, Cotton, Wheat, Sorghum, and Vegetables) and By Technology (GM/GE/Hybrid and Open Pollinated)” provides a comprehensive analysis of the seeds market in the US. The report covers the overall market size in terms of revenue, segmentations on the basis of crop, type of seed, geographical region, trends and developments, regulations for patents in the US,
Philippines Logistics and Warehousing Market Outlook to 2024: Ken Research
The report titled “Philippines Logistics and Warehousing Market Outlook to 2024 – By Freight Forwarding (Air, Sea, Land), Domestic and International Freight Flow Corridor; By Warehousing (Industrial/Retail Freight, Container Freight, Cold Storage, Agriculture and Others), Express and E-commerce Logistics, Balikbayan Box, Third Party Logistics” provides a comprehensive analysis of the logistics market of Philippines. The report also covers logistics infrastructure in the country, value chain analysis of the market, the
Growing Ultimatum of the Global Temporary Power System Market Outlook: Ken Resea …
The temporary power system majorly empower of standby generators which involve both gas generators and diesel generators along with the other apparatus. Whereas, the temporary power is devoted to be liberated source of electrical energy which has its effectiveness to help the pivotal electrical systems during the harm of normal supply of power during the precise time period. Generally, the temporary power systems used and deployed to safeguard the power
UK Executive MBA Market Outlook to 2023: Ken Research
The report titled “UK Executive MBA Market Outlook to 2023 - By Type of Program (Structured and Customized), By Electives, By Blended Learning (Online & Offline and only Offline), By Program Duration and By Course Type (Part Time only, Full Time only or Either Full or Part Time)” provides a comprehensive analysis on the Executive MBA Industry of UK. The report covers various aspects including introduction on Executive MBA market,
More Releases for Obesity
Sternal Closure System Market Demand Obesity 2025
Global Sternal Closure System Market: Overview Sternal closure is necessitated by a heart surgery or surgeries of the thoracic cavities. It is used to close the sternum. A perfect sternal closure is predicted to bring about stability, lessen post-operative complications, and also reduce hospitalization stay. Overall, it is meant to be cost-effective. The market for sternal closure systems has been rising steadily because of the surging patient population, alongside the increasing
Obesity Management Congress 2018
Obesity can be managed by combination of lifestyle change, exercise and healthy diet plans. In case of severe Obesity bariatric surgery and medications will be employed. People who have gone through bariatric surgery which have suppressed hunger and the mechanism for which causes obesity based type 2 diabetes is reversed and it also causes sixty to eighty percent weight loss for a long term. But it has it cons
Obesity Therapeutic and Disease Pipeline Review H2
Summary Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of sleep and certain medications. Treatment includes healthy lifestyle, medications and surgery. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Obesity - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development
Obesity Management Market | Global Industry Analysis 2027
High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking better return on investments. In the long run, risks and
Obesity Treatment Market driven by rise in childhood obesity rates
Obesity is a disorder in which excess body fat gets accumulated to such extent that it may have negative effects on health. It occurs over time when people eat more calories than they utilize. The reasons for obesity can be medical problems, inactivity, genetics, family lifestyle, unhealthy diet, medications, age, and pregnancy. Being obese increases the risk of diabetes, heart disease, stroke, arthritis, and some type of cancers. Obesity treatment
Obesity Epidemic Among Children Triggering Numerous Ailments
I-Newswire (February 22, 2012) Former U.S. Surgeon General Richard Carmona recently stated, “Because of the increasing rates of obesity, unhealthy eating habits and physical inactivity, we may see the first generation that will be less healthy and have a shorter life expectancy than their parents.” Carmona’s statement reflects findings that nearly one in three children is overweight or obese. Children are developing obesity-related diseases, previously considered primarily adult